Analysts have slightly adjusted their price target for ProAssurance, maintaining a fair value estimate of $22.67 while taking into account a marginally lower outlook for revenue growth and profit margins.
What's in the News
- ProAssurance reported it repurchased zero shares between April 1, 2025 and June 30, 2025, resulting in no additional spending on buybacks in this period (Key Developments).
- With this update, the company has fully completed its buyback program. Since February 24, 2011, it has repurchased a total of 12,758,534 shares, which represent 22.5% of outstanding shares and $490.42 million in total repurchases (Key Developments).
Valuation Changes
- The Fair Value Estimate remains steady at $22.67 per share, with no change from the previous analysis.
- The Discount Rate is unchanged at 6.78%.
- Revenue Growth projections have declined modestly, moving from -1.80% to -2.14%.
- The Net Profit Margin is slightly lower, changing from 6.69% to 6.66%.
- The Future P/E Ratio has increased marginally, rising from 20.06x to 20.37x.
Have other thoughts on ProAssurance?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.